VCI Global Signs Definitive Agreement to Acquire Lux-Motion, Expanding Into US$350 Billion Automotive E-Commerce Market
Notified -
Globe Newswire17-03-2025, 22:33
Teva Presents Positive Efficacy and Safety Data of AJOVY® (fremanezumab) for the Prevention of Episodic Migraine in Children and Adolescents from Phase 3 SPACE Trial 4-12-2024, 14:00